BMO Capital Markets’ Evan Seigerman joins BiotechTV for Analyst Thursdays
- blonca9
- Aug 31, 2023
- 1 min read
Evan Seigerman gives his take on biotech and discusses the Medicare negotiation list, Lilly, Amgen, Skyscraper-01, Structure Therapeutics, Disc Medicine, Replimune, and other upcoming catalysts.